Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Express Scripts Holding Co    ESRX

Delayed Quote. Delayed  - 08/26 10:00:00 pm
72.31 USD   +0.79%
08/25 NASDAQ 100 MOVE : Dltr, mu
08/24 LAWSUIT FOR LON : ESRX) Filed
08/18 EXPRESS SCRIPTS : Will your prescriptions be covered in 2017?
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Express Scripts Holding Co : quaterly earnings release

share with twitter share with LinkedIn share with facebook
share via e-mail
0
02/13/2013 | 03:15pm CEST

The company will report its earnings for Q4 2012 on 02/18/2013. Generally, the company reports earnings worse than estimates. In recent months, the 11 analysts from Thomson Reuters consensus have revised their EPS estimates downward. Below, a summary of publications and estimates for Express Scripts Holding Co.

Quarterly resultsQ1
2012
Q2
2012
Q3
2012
Q4
2012 (e)
Q1
2013 (e)
Sales
Million $
Released
Forecast
Spread
12 133
11 485
5,6%
27 693
26 541
4,3%
26 999
27 465
-1,7%

27 240

25 466
Operating income (EBITDA)
Million $
Released
Forecast
Spread
656
686
-4,3%
1 493
1 366
9,3%
1 621
1 548
4,8%

1 671

1 522
Operating profit (EBIT)
Million $
Released
Forecast
Spread
630
650
-3,1%
1 054
1 166
-9,6%
1 534
1 316
17%

1 482

1 380
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
435

364

649





Net income
Million $
Released
Forecast
Spread
268
338
-21%
171
498
-66%
391
438
-11%

499

498
EPS
 $
Released
Forecast
Spread
0,55
0,69
-21%
0,21
0,60
-65%
0,47
0,57
-18%

0,60

0,67
Announcement Date05/10/201208/07/201211/05/2012

Annual earnings per share is expected at 1.87 USD for 2012 (- 26% from 2011). A summary of annual publications and estimates is available below.

Annual results2009201020112012 (e)2013 (e)
Sales
Million $
Released
Forecast
Spread
24 749
23 995
3,1%
44 973
45 236
-0,58%
46 128
45 613
1,1%

94 051

101 169
Operating income (EBITDA)
Million $
Released
Forecast
Spread
1 608
1 678
-4,2%
2 408
2 410
-0,09%
2 658
2 683
-0,94%

5 485

6 731
Operating profit (EBIT)
Million $
Released
Forecast
Spread
1 498
1 559
-3,9%
2 164
2 224
-2,7%
2 559
2 586
-1,1%

4 790

5 816
Pre-Tax Profit (EBT)
 
Released
Forecast
Spread










Net income
Million $
Released
Forecast
Spread
827
817
1,2%
1 181
1 201
-1,7%
1 276
1 438
-11%

1 362

2 096
EPS
 $
Released
Forecast
Spread
1,56
1,54
1,0%
2,17
2,22
-2,5%
2,53
2,83
-10%

1,87

2,82
Announcement Date02/24/201002/16/201102/22/2012

© 4-traders.com 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EXPRESS SCRIPTS HOLDING CO
08/25 NASDAQ 100 MOVERS : Dltr, mu
08/24 LAWSUIT FOR LONG-TERM INVESTORS IN S : ESRX) Filed
08/18 EXPRESS SCRIPTS : Will your prescriptions be covered in 2017?
08/17 EXPRESS SCRIPTS : to fund $175,000 for Christian Hospital's CHAP partnership wit..
08/13 EXPRESS SCRIPTS : A secretive board controls access to prescription drugs for mi..
08/10 RITE AID : Toms River man battles Rite Aid for refund
08/03 NOVO NORDISK A/S : Diabetes drug shunned by Express Scripts Business briefing
08/02DJQuick CFO Exits Can Spell Trouble -- WSJ
08/01DJA Quick CFO Exit Can Spell Trouble
07/29 EXPRESS SCRIPTS HOLDING CO. : Other Events, Financial Statements and Exhibits (f..
More news
Sector news : Drug Retailers - NEC
08/22DJSINOPHARM GROUP : 1st Half Net Profit CNY2.53 Billion, Up 32% on Year
08/17DJTarget Dims Outlook as Sales Struggle
08/09DJPatient Survey Company Press Ganey to Sell Itself to Swedish Firm EQT
08/09DJValeant Posts a Loss and Says It Will Retool
08/05DJAbbVie Sues Amgen Over Humira
More sector news : Drug Retailers - NEC
News from SeekingAlpha
08/24 Tracking Larry Robbins' Glenview Capital Management Portfolio - Q2 2016 Updat..
08/23 Tracking Wallace Weitz's Weitz Investment Management Portfolio - Q2 2016 Upda..
08/12 DIPLOMAT PHARMACY : The Correction Seems Overdone, Overlooking The Performance
08/11 7 INTRIGUING HEALTHCARE GROWTH STOCK : Part 2
08/03 BIOTECH DAILY DIGEST : A Buyout For Biogen? The Rally Continues. Spotlight On Li..
Advertisement
Financials ($)
Sales 2016 101 827 M
EBIT 2016 6 532 M
Net income 2016 2 912 M
Debt 2016 12 635 M
Yield 2016 -
P/E ratio 2016 15,78
P/E ratio 2017 14,30
EV / Sales 2016 0,57x
EV / Sales 2017 0,54x
Capitalization 45 571 M
More Financials
Chart EXPRESS SCRIPTS HOLDING CO
Duration : Period :
Express Scripts Holding Co Technical Analysis Chart | ESRX | US30219G1085 | 4-Traders
Full-screen chart
Technical analysis trends EXPRESS SCRIPTS H...
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 23
Average target price 82,1 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Timothy C. Wentworth President, Chief Executive Officer & Director
George Paz Chairman
Christine Houston Senior Vice President-Operations
Eric R. Slusser Chief Financial Officer & Executive Vice President
Steven B. Miller Chief Medical Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
EXPRESS SCRIPTS HOLDIN..-17.27%45 571
CVS HEALTH CORP-4.61%99 435
WALGREENS BOOTS ALLIAN..-6.77%85 925
MCKESSON CORPORATION-7.32%41 256
CARDINAL HEALTH INC-11.11%25 280
AMERISOURCEBERGEN CORP..-17.32%18 413
More Results